Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Behavioral family counseling and naltrexone for male opioid-dependent patients.

Fals-Stewart W, O'Farrell TJ.

J Consult Clin Psychol. 2003 Jun;71(3):432-42.

PMID:
12795568
2.

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.

Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. Review.

3.

Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

Carroll KM, Ball SA, Nich C, O'Connor PG, Eagan DA, Frankforter TL, Triffleman EG, Shi J, Rounsaville BJ.

Arch Gen Psychiatry. 2001 Aug;58(8):755-61.

4.

Behavioral naltrexone therapy: an integrated treatment for opiate dependence.

Rothenberg JL, Sullivan MA, Church SH, Seracini A, Collins E, Kleber HD, Nunes EV.

J Subst Abuse Treat. 2002 Dec;23(4):351-60.

PMID:
12495797
5.

Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence.

Church SH, Rothenberg JL, Sullivan MA, Bornstein G, Nunes EV.

Am J Drug Alcohol Abuse. 2001 Aug;27(3):441-52.

PMID:
11506261
6.

Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?

Nunes EV, Rothenberg JL, Sullivan MA, Carpenter KM, Kleber HD.

Am J Drug Alcohol Abuse. 2006;32(4):503-17.

PMID:
17127538
7.

Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study.

Rabinowitz J, Cohen H, Tarrasch R, Kotler M.

Drug Alcohol Depend. 1997 Aug 25;47(2):77-86. Review.

PMID:
9298329
8.

Naltrexone induction: psychologic and pharmacologic strategies.

Kleber HD, Kosten TR.

J Clin Psychiatry. 1984 Sep;45(9 Pt 2):29-38.

PMID:
6469934
9.

[Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].

Roozen HG, Deden AL, Kerkhof AJ, Vorsteveld JP, van den Brink W.

Ned Tijdschr Geneeskd. 1997 Dec 6;141(49):2377-80. Dutch.

PMID:
9554156
10.

Naltrexone pharmacotherapy for opioid dependent federal probationers.

Cornish JW, Metzger D, Woody GE, Wilson D, McLellan AT, Vandergrift B, O'Brien CP.

J Subst Abuse Treat. 1997 Nov-Dec;14(6):529-34.

PMID:
9437624
11.

Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.

Mannelli P, Patkar AA, Peindl K, Murray HW, Wu LT, Hubbard R.

J Clin Psychopharmacol. 2007 Oct;27(5):468-74.

PMID:
17873678
12.

Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.

Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.

Arch Gen Psychiatry. 2005 Oct;62(10):1157-64.

PMID:
16203961
13.

[Alcohol consumption in opioid-dependence patients in treatment with naltrexone].

Ochoa Mangado E, Arias Horcajadas F.

Actas Esp Psiquiatr. 2000 Jul-Aug;28(4):239-49. Spanish.

PMID:
11116795
14.
15.

Psychotherapy/counseling for opiate addicts: strategies for use in different treatment settings.

Rounsaville BJ, Kleber HD.

Int J Addict. 1985 Jun-Jul;20(6-7):869-96. Review.

PMID:
3908340
16.

Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings.

Sinha R, Kimmerling A, Doebrick C, Kosten TR.

Psychopharmacology (Berl). 2007 Mar;190(4):569-74. Epub 2006 Nov 29.

PMID:
17136399
17.

Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients.

Stella L, D'Ambra C, Mazzeo F, Capuano A, Del Franco F, Avolio A, Ambrosino F.

Life Sci. 2005 Oct 7;77(21):2717-22.

PMID:
15979652
18.

Retention in naltrexone implant treatment for opioid dependence.

Kun√łe N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen O, Waal H.

Drug Alcohol Depend. 2010 Sep 1;111(1-2):166-9. doi: 10.1016/j.drugalcdep.2010.03.021. Epub 2010 May 31.

PMID:
20570059
19.

Naltrexone and buprenorphine combination in the treatment of opioid dependence.

Gerra G, Fantoma A, Zaimovic A.

J Psychopharmacol. 2006 Nov;20(6):806-14. Epub 2006 Jan 9.

PMID:
16401652
20.

Naltrexone for heroin dependence treatment in St. Petersburg, Russia.

Krupitsky EM, Zvartau EE, Masalov DV, Tsoi MV, Burakov AM, Egorova VY, Didenko TY, Romanova TN, Ivanova EB, Bespalov AY, Verbitskaya EV, Neznanov NG, Grinenko AY, O'Brien CP, Woody GE.

J Subst Abuse Treat. 2004 Jun;26(4):285-94.

PMID:
15182893

Supplemental Content

Support Center